Simultaneous exposure of non-diabetics to high levels of dioxins and mercury increases their risk of insulin resistance

Journal of Hazardous Materials

Volumn 185, Issue 2-3, 2011, Pages 749-755

  Chang, Jung Wei ^a   Chen, Hsiu Ling ^b   Su, Huey Jen ^a,c   Liao, Po Chi ^a,c   Guo, How Ran ^a,d   Lee, Ching Chang ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Dioxins; Insulin resistance; Integrated effects; Type 2 diabetes

Indexed keywords

CHLOR-ALKALI; CROSS-SECTIONAL STUDY; DIOXINS; ENDOCRINE FUNCTIONS; HIGH EXPOSURES; INSULIN RESISTANCE; INTEGRATED EFFECTS; METABOLIC SYNDROMES; TYPE-2 DIABETES;

BLOOD; INSULIN; PHENOLS;

MERCURY (METAL);

ALKALI; DIOXIN; MERCURY; PENTACHLOROPHENOL;

BLOOD; DIABETES; DIOXIN; ENDOCRINOLOGY; HORMONE; MERCURY (ELEMENT); POLLUTION EXPOSURE; RISK ASSESSMENT;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; EXPOSURE; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; PANCREAS ISLET BETA CELL; RISK ASSESSMENT;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIOXINS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; MERCURY; MIDDLE AGED;

EID: 78649970162     PISSN: 03043894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2010.09.084     Document Type: Article

References (41)

1. Bertazzi P.A., Bernucci I., Brambilla G., Consonni D., Pesatori A.C. The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ. Health Perspect. 1998, 106(Suppl. 2):625-633.
2. Calvert G.M., Sweeney M.H., Deddens J., Wall D.K. Evaluation of diabetes mellitus, serum glucose, and thyroid function among United States workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup. Environ. Med. 1999, 56:270-276.
3. Chang J.W., Chen H.L., Su H.J., Liao P.C., Guo H.R., Lee C.C. Dioxin exposure and insulin resistance in Taiwanese living near a highly contaminated area. Epidemiology 2010, 21:56-61.
4. Steenland K., Piacitelli L., Deddens J., Fingerhut M., Chang L.I. Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Natl. Cancer Inst. 1999, 91:779-786.
5. Remillard R.B., Bunce N.J. Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ. Health Perspect. 2002, 110:853-858.
6. Dolbec J., Mergler D., Sousa Passos C.J., Sousa de Morais S., Lebel J. Methylmercury exposure affects motor performance of a riverine population of the Tapajos river, Brazilian Amazon. Int. Arch. Occup. Environ. Health. 2000, 73:195-203.
7. WHO/IPCS, Methylmercury: Environmental Aspect, Environmental Health Criteria 101.IPCS, World Health Organization, Geneva, 1990a.
8. WHO/IPCS, Methylmercury: Environmental Aspects, Environmental Health Criteria 101.IPCS, World Health Organization, Geneva, 1990b.
9. Takeuchi T., Eto K. Pathology and pathogenesis of Minamata disease. Minamata Diseases-Methyl Mercury Poisoning in Minamata and Niigata, Japan 1997, 103-141. T. Tsubaki, K. Irukayama (Eds.).
10. Shigenaga K. Pancreatic islet injury induced by methyl mercuric chloride light and electron microscopic studies. Kumamoto Med. J. 1976, 29:67-81.
11. Goldstein B.J. Insulin resistance as the core defect in type 2 diabetes mellitus. Am. J. Cardiol. 2002, 90:3G-10G.
12. Cheal K.L., Abbasi F., Lamendola C., McLaughlin T., Reaven G.M., Ford E.S. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004, 53:1195-1200.
13. Everett C.J., Frithsen I.L., Diaz V.A., Koopman R.J., Simpson W.M., Mainous A.G. Association of a polychlorinated dibenzo-p-dioxin, a polychlorinated biphenyl, and DDT with diabetes in the 1999-2002 National Health and Nutrition Examination Survey. Environ. Res. 2007, 103:413-418.
14. Longnecker M.P., Michalek J.E. Serum dioxin level in relation to diabetes mellitus among Air Force veterans with background levels of exposure. Epidemiology 2000, 11:44-48.
15. Alonso-Magdalena P., Morimoto S., Ripoll C., Fuentes E., Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ. Health Perspect. 2006, 114:106-112.
16. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303-1310.
17. Chen H.L., Liao P.C., Su H.J., Guo Y.L., Lee C.C. Profile of PCDD/F levels in serum of general Taiwanese between different gender, age and smoking status. Sci. Total Environ. 2005, 337:31-43.
18. Chen H.L., Su H.J., Lee C.C. Patterns of serum PCDD/Fs affected by vegetarian regime and consumption of local food for residents living near municipal waste incinerators from Taiwan. Environ. Int. 2006, 32:650-655.
19. Lee C.C., Lin W.T., Liao P.C., Su H.J., Chen H.L. High average daily intake of PCDD/Fs and serum levels in residents living near a deserted factory producing pentachlorophenol (PCP) in Taiwan: influence of contaminated fish consumption. Environ. Pollut. 2006, 141:381-386.
20. United Nations Environmental Programme (UNEP) Global Mercury Assessment Report Current Mercury Exposures and Risk Evaluations for Humans, 2003, http://www.chem.unep.ch/MERCURY/Report/Final%2520report/chapter4.doc.
21. Chang J.W., Pai M.C., Chen H.L., Guo H.R., Su H.J., Lee C.C. Cognitive function and blood methylmercury in adults living near a deserted chloralkali factory. Environ. Res. 2008, 108:334-339.
22. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
23. Balkau B., Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet. Med. 1999, 16:442-443.
24. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report, Circulation 106 (2002) 3143-3421.
25. Lee D.H., Lee I.K., Porta M., Steffes M., Jacobs D.R. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 2007, 50:1841-1851.
26. Jørgensen M.E., Borch-Johnsen K., Bjerregaard P. A cross-sectional study of the association between persistent organic pollutants and glucose intolerance among Greenland Inuit. Diabetologia 2008, 51:1416-1422.
27. Janssen I., Heymsfield S.B., Allison D.B., Kotler D.P., Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J. Clin. Nutr. 2002, 75:683-688.
28. Michalek J.E., Pirkle J.L., Caudill S.P., Tripathi R.C., Patterson D.G., Needham L.L. Pharmacokinetics of TCDD in veterans of Operation Ranch Hand: 10-year follow-up. J. Toxicol. Environ. Health 1996, 47:209-220.
29. Turner N.C., Clapham J.C. Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: current status and therapeutic possibilities. Prog. Drug. Res. 1998, 5:33-94.
30. Dohr O., Vogel C., Abel J. Modulation of growth factor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Exp. Clin. Immunogenet. 1994, 11:142-148.
31. Vogel C., Abel J. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on growth factor expression in the human breast cancer cell line MCF-7. Arch. Toxicol. 1995, 69:259-265.
32. Greene M.E., Pitts J., McCarville M.A., Wang X.S., Newport J.A., Edelstein C. PPARgamma: observations in the hematopoietic system. Prostaglandins Other Lipid Mediat. 2000, 62:45-73.
33. Lee D.H., Lee I.K., Song K., Steffes M., Toscano W., Baker B.A., Jacobs D.R. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care 2006, 29:1638-1644.
34. Cranmer M., Louie S., Kennedy R.H., Kern P.A., Fonseca V.A. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is associated with hyperinsulinemia and insulin resistance. Toxicol. Sci. 2000, 56:431-436.
35. Evans J.L., Goldfi{ligature}ne I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 2002, 23:599-622.
36. Shenker B.J., Guo T.L., Shapiro I.O.I.M. Induction of apoptosis in human T-cells by methylmercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol. Appl. Pharmacol. 1999, 157:23-35.
37. Chen Y.W., Huang C.F., Tsai K.S., Yang R.S., Yen C.C., Yang C.Y., Lin-Shiau S.Y., Liu S.H. Methylmercury induces pancreatic beta-cell apoptosis and dysfunction. Chem. Res. Toxicol. 2006, 19:1080-1085.
38. Chen Y.W., Huang C.F., Tsai K.S., Yang R.S., Yen C.C., Yang C.Y., Lin-Shiau S.Y., Liu S.H. The role of phosphoinositide 3-kinase/Akt signaling in low-dose mercury-induced mouse pancreatic beta-cell dysfunction in vitro and in vivo. Diabetes 2006, 55:1614-1624.
39. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B., Monauni T., Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23:57-63.
40. Chang A.M., Smith M.J., Bloem C.J., Galecki A.T., Halter J.B., Supiano M.A. Limitation of the homeostasis model assessment to predict insulin resistance and beta-cell dysfunction in older people. J. Clin. Endocrinol. Metab. 2006, 91:629-634.
41. Gilbertson M., Brophy J. Community health profile of Windsor, Ontario, Canada: anatomy of a Great Lakes Area of concern. Environ. Health Perspect. 2001, 109:827-843.